Perfusion Tech ApS: Financial statements 2025
CVR: 38238213
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Perfusion Tech ApS (CVR 38238213) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -6,142,804 and a net result of DKK -12,724,708 compared with DKK -14,469,520 the year before. Equity in the 2025 report amounted to DKK -9,640,655. The company had 11 employees in the financial year.
- Gross Profit
- DKK -6,142,804
- Profit/Loss
- DKK -12,724,708
- Equity
- DKK -9,640,655
- Total Assets
- DKK 4,586,810
- Employees
- 11
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -6.1 mio. | -12.7 mio. | -9.6 mio. | 11 |
| 2024 | - | -9 mio. | -14.5 mio. | 2.1 mio. | 11 |
| 2023 | - | -5.4 mio. | -9.5 mio. | 2.9 mio. | 8 |
| 2022 | - | -4.2 mio. | -6.6 mio. | 1.2 mio. | 7 |
| 2021 | - | -1.1 mio. | -2.1 mio. | -3.9 mio. | 4 |
Official annual report
How creditworthy is Perfusion Tech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of September 29, 2025, Declan Cassells is registered as director of Perfusion Tech ApS.
As of September 29, 2025, Pernille Charlotte Singer has stepped down as adm. dir. of Perfusion Tech ApS.
Perfusion Tech ApS has published its annual report for 2024. Gross profit came to DKK -9,021,930, and the net result was DKK -14,469,520.
As of June 4, 2025, Jeppe Øvli Øvlesen has left the board of directors of Perfusion Tech ApS.
As of June 4, 2025, Henrik Christensen has left the board of directors of Perfusion Tech ApS.
As of June 4, 2025, Thomas Engelbrecht Nordkild Jonassen has left the board of directors of Perfusion Tech ApS.
As of June 4, 2025, Mads Aagaard Linde Madsen has left the board of directors of Perfusion Tech ApS.
As of June 4, 2025, is registered as an owner of Perfusion Tech ApS with an ownership share of 100%.
As of April 22, 2025, Sten Scheibye has left the board of directors of Perfusion Tech ApS.
About Perfusion Tech ApS
Perfusion Tech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Perfusion Tech IVS. The management consists of Declan Cassells. The board consists of Declan Cassells. The company is owned by Renew Pharmaceuticals Limited. According to the 2025 annual report, the company had an average of 11 employees. In 2025, the company reported a gross profit of DKK -6,142,804 and a net result of DKK -12,724,708 compared with DKK -14,469,520 the year before. Equity in the 2025 report amounted to DKK -9,640,655.